0001179110-12-015846.txt : 20121108 0001179110-12-015846.hdr.sgml : 20121108 20121108195650 ACCESSION NUMBER: 0001179110-12-015846 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121106 FILED AS OF DATE: 20121108 DATE AS OF CHANGE: 20121108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 121191416 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2012-11-06 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001312622 Foster-Cheek Kaye I C/O ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Global Human Resources Common Stock 2012-11-06 4 M 0 4775 37.68 A 32611 D Common Stock 2012-11-06 4 S 0 7112 75.90 D 25499 D Stock Option (right to Buy) 37.68 2012-11-06 4 M 0 4775 0.00 D 2022-03-29 Common Stock 4775 33425 D The shares were sold at prices ranging from $75.76 to $76.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. 12.5% of the shares subject to the option became exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months. /s/ Matthew K. Fust, Attorney-in-fact 2012-11-08